Compound Detail
CHEMBL364713
NOSCAPINE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL364713 |
| Name | NOSCAPINE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | AKNNEGZIBPJZJG-MSOLQXFVSA-N |
| Therapeutic | ✓ Yes |
15
Targets
38
Activities
3
Assay Types
7
PK Parameters
20
Publications
8
Known Names
3
Indications
Molecular Properties
413.4
MW (Da)
2.88
ALogP
8
HBA
0
HBD
75.7
PSA (Ų)
0.71
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Cough Leukemia, Lymphocytic, Chronic, B-Cell Multiple Myeloma
ATC Classification
R05DA07
noscapine
Level 1: RESPIRATORY SYSTEM
Level 2: COUGH AND COLD PREPARATIONS
Activity Summary
IC50 32 meas. best 6.4
EC50 3 meas. best 4.74
Kd 3 meas. best 6.24
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Cytochrome P450 2C19 CHEMBL3622 | IC50 | 6.4 | 6.4 | 400.3 | 1 |
| Tubulin beta CHEMBL3832942 | Kd | 6.24 | 6.24 | 579.0 | 1 |
| Tubulin CHEMBL2095182 | Kd | 5.73 | 5.73 | 1860.0 | 1 |
| Solute carrier family 22 member 2 CHEMBL1743122 | IC50 | 5.58 | 5.58 | 2600.0 | 1 |
| Cytochrome P450 2C9 CHEMBL3397 | IC50 | 5.09 | 5.09 | 8177.3 | 1 |
| CCRF-CEM CHEMBL382 | IC50 | 4.84 | 4.84 | 14500.0 | 1 |
| NCI/ADR-RES CHEMBL613829 | IC50 | 4.76 | 4.76 | 17400.0 | 1 |
| HeLa CHEMBL399 | EC50 | 4.74 | 4.74 | 18400.0 | 1 |
| MCF7 CHEMBL387 | IC50 | 4.73 | 4.4117 | 18800.0 | 6 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 4.7 | 4.3525 | 20000.0 | 4 |
| HeLa CHEMBL399 | IC50 | 4.62 | 4.61 | 24000.0 | 4 |
| A549 CHEMBL392 | EC50 | 4.6 | 4.6 | 25000.0 | 1 |
| Multidrug and toxin extrusion protein 1 CHEMBL1743126 | IC50 | 4.46 | 4.46 | 34500.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 4.41 | 4.3367 | 39000.0 | 3 |
| U-251 CHEMBL615022 | IC50 | 4.4 | 4.4 | 40000.0 | 1 |
| A549 CHEMBL392 | IC50 | 4.2 | 4.17 | 62900.0 | 2 |
| MDA-MB-231 CHEMBL400 | IC50 | 4.19 | 4.19 | 64000.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 4.16 | 4.16 | 69700.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 345.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 524.0 | ng.hr.mL-1 | Mus musculus |
| CL | 96.8 | mL.min-1.kg-1 | Mus musculus |
| F | 14.1 | % | Mus musculus |
| F | 30.0 | % | Homo sapiens |
| T1/2 | 0.8333 | hr | Mus musculus |
| T1/2 | 4.5 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 168 |
| - | 10.5281/zenodo.13943903 | ADMET | 89 |
| 38352836 | 10.1021/acsmedchemlett.3c00462 | MOLM-13 | 9 |
| 25811651 | 10.1021/jm501180v | Tubulin | 8 |
| 22320354 | 10.1021/jm200848t | NON-PROTEIN TARGET | 8 |
| 25811651 | 10.1021/jm501180v | HeLa | 8 |
| 25811651 | 10.1021/jm501180v | U-251 | 7 |
| 16279766 | 10.1021/jm050674q | Mus musculus | 6 |
| 25811651 | 10.1021/jm501180v | NON-PROTEIN TARGET | 6 |
| 30156410 | 10.1021/acs.jmedchem.8b00986 | Unchecked | 6 |
| 22320354 | 10.1021/jm200848t | SNU-398 | 5 |
| 30156410 | 10.1021/acs.jmedchem.8b00986 | MCF7 | 4 |
| 30156410 | 10.1021/acs.jmedchem.8b00986 | PANC-1 | 4 |
| 22320354 | 10.1021/jm200848t | Molecular identity unknown | 3 |
| 15828811 | 10.1021/jm0494220 | HEK293 | 3 |
| 25050880 | 10.1016/j.ejmech.2014.07.050 | Tubulin | 3 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Histamine H1 receptor | 3 |
Data from ChEMBL 36 via Core Engine